New Targets = Better Standard of Care

Alexander Bastian

Video Categories: Targeted Therapies

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.
January 20, 2016

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Dr Wainberg and Dr Gerson talk about the results of using investigational agent BBI608 combined with another drug that is used as a standard of care.

July 25, 2018

How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their Patients

Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.